Jang Hoon, Bae Woong Jin, Kim Su Jin, Cho Hyuk Jin, Yuk Seung Mo, Han Dong Seok, Youn Chang Shik, Kwon Eun Bi, Hwang Sung Yeoun, Kim Sae Woong
Department of Urology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Republic of Korea.
Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
BMC Complement Altern Med. 2017 Feb 24;17(1):129. doi: 10.1186/s12906-017-1588-4.
Hypercholesterolaemia (HC) is a major risk factor for ischemic heart disease and is also known to be a risk factor for erectile dysfunction (ED). ED caused by HC is thought to be related to HC-induced oxidative stress damage in the vascular endothelium and erectile tissue. KH-204 is an herbal formula with a strong antioxidant effect. We evaluated the effects of KH-204 on erectile function in a rat model of HC-induced ED.
Male Sprague-Dawley rats (6 weeks old) were divided into normal control, high-fat and cholesterol diet (HFC), and HFC with KH-204 treatment (HFC + KH) groups (n = 12 each). Normal control group rats were fed normal chow diet. HFC and HFC + KH group rats were fed high-fat and cholesterol diets and treated with or without daily oral doses of KH-204 for 12 weeks. Subsequently, intracavernous pressure (ICP) and mean arterial pressure (MAP) were measured, and lipid profiles, expression of endothelial (eNOS) and neuronal (nNOS) nitric oxide synthase, oxidative stress (8-hydroxy-2-deoxyguanosine), and ratio of smooth muscle cells and collagen fibres were evaluated in the serum and corpora tissue.
Compared to the HFC group, the HFC + KH group showed statistically significant increases in peak ICP and ICP/MAP ratio, expression of eNOS and nNOS, and ratio of smooth muscle cells and collagen fibres (p < 0.05). The HFC + KH group also showed statistically significant decreases in oxidative stress (p < 0.05). Further the lipid profiles of this group were ameliorated compared to those of the HFC group (p < 0.05).
The current study shows that the antioxidant and hypolipidemic effects of KH-204 are effective in ameliorating ED by restoring endothelial dysfunction and suggests that KH-204 may be a potential therapeutic agent for ED by correcting the fundamental cause of ED.
高胆固醇血症(HC)是缺血性心脏病的主要危险因素,也是勃起功能障碍(ED)的危险因素。HC所致的ED被认为与HC诱导的血管内皮和勃起组织氧化应激损伤有关。KH-204是一种具有强大抗氧化作用的草药配方。我们在HC诱导的ED大鼠模型中评估了KH-204对勃起功能的影响。
将6周龄雄性Sprague-Dawley大鼠分为正常对照组、高脂高胆固醇饮食(HFC)组和HFC+KH-204治疗组(每组n=12)。正常对照组大鼠喂食正常饲料。HFC组和HFC+KH组大鼠喂食高脂高胆固醇饮食,并分别接受或不接受每日口服KH-204治疗12周。随后,测量海绵体内压(ICP)和平均动脉压(MAP),并评估血清和海绵体组织中的血脂谱、内皮型(eNOS)和神经型(nNOS)一氧化氮合酶的表达、氧化应激(8-羟基-2-脱氧鸟苷)以及平滑肌细胞与胶原纤维的比例。
与HFC组相比, HFC+KH组的峰值ICP和ICP/MAP比值、eNOS和nNOS的表达以及平滑肌细胞与胶原纤维的比例均有统计学显著增加(P<0.05)。HFC+KH组的氧化应激也有统计学显著降低(P<0.05)。此外,该组的血脂谱与HFC组相比有所改善(P<0.05)。
本研究表明,KH-204的抗氧化和降血脂作用可通过恢复内皮功能障碍有效改善ED,并提示KH-204可能是一种通过纠正ED根本原因来治疗ED的潜在治疗药物。